Recurrent erysipelas: risk factors
Clicks: 245
ID: 118275
2004
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
69.2
/100
239 views
196 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Patients with erysipelas, especially when it involves the lower limb, should be instructed to reduce weight, control venous insufficiency and/or lymphedema and to emphasize prevention and treatment of tinea pedis. The role of prophylactic antibiotics requires further study.
| Reference Key |
f2004journalrecurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Pavlotsky F;Amrani S;Trau H;; |
| Journal | journal der deutschen dermatologischen gesellschaft = journal of the german society of dermatology : jddg |
| Year | 2004 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
adolescent
aged
middle aged
Child
Recurrence
risk factors
80 and over
Retrospective Studies
erysipelas / etiology*
hospitalization / statistics & numerical data
erysipelas / diagnosis
erysipelas / epidemiology
pmid:16279242
doi:10.1046/j.1439-0353.2004.03028.x
felix pavlotsky
shalom amrani
henry trau
leg dermatoses / diagnosis
leg dermatoses / etiology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.